Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease

Mark C. Walters, Karen Hardy, Sandie Edwards, Thomas Adamkiewicz, James Barkovich, Francoise Bernaudin, George R. Buchanan, Nancy Bunin, Roswitha Dickerhoff, Roger Giller, Paul R. Haut, John Horan, Lewis L. Hsu, Naynesh Kamani, John E. Levine, David Margolis, Kwaku Ohene-Frempong, Melinda Patience, Rupa Redding-Lallinger, Irene A G Roberts & 4 others Zora R. Rogers, Jean E. Sanders, J. Paul Scott, Keith M. Sullivan

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

We conducted a prospective, multicenter investigation of human-leukocyte antigen (HLA) identical sibling bone marrow transplantation (BMT) in children with severe sickle cell disease (SCD) between 1991 and 2000. To determine if children were protected from complications of SCD after successful BMT, we extended our initial study of BMT for SCD to conduct assessments of the central nervous system (CNS) and of pulmonary function 2 or more years after transplantation. In addition, the impact on gonadal function was studied. After BMT, patients with stroke who had stable engraftment of donor cells experienced no subsequent stroke events after BMT, and brain magnetic resonance imaging (MRI) exams demonstrated stable or improved appearance. However, 2 patients with graft rejection had a second stroke after BMT. After transplantation, most patients also had unchanged or improved pulmonary function. Among the 11 patients who had restrictive lung changes at baseline, 5 were improved and 6 had persistent restrictive disease after BMT. Of the 2 patients who had obstructive changes at baseline, 1 improved and 1 had worsened obstructive disease after BMT. There was, however, significant gonadal toxicity after BMT, particularly among female recipients. In summary, individuals who had stable donor engraftment did not experience sickle-related complications after BMT, and were protected from progressive CNS and pulmonary disease.

Original languageEnglish (US)
Pages (from-to)263-272
Number of pages10
JournalBiology of Blood and Marrow Transplantation
Volume16
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Sickle Cell Anemia
Bone Marrow Transplantation
Central Nervous System
Lung
Stroke
Transplantation
Tissue Donors
Central Nervous System Diseases
Graft Rejection
HLA Antigens
Lung Diseases
Siblings
Magnetic Resonance Imaging
Brain

Keywords

  • Bone marrow transplantation
  • Long-term follow-up
  • Sickle cell anemia

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Walters, M. C., Hardy, K., Edwards, S., Adamkiewicz, T., Barkovich, J., Bernaudin, F., ... Sullivan, K. M. (2010). Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease. Biology of Blood and Marrow Transplantation, 16(2), 263-272. https://doi.org/10.1016/j.bbmt.2009.10.005

Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease. / Walters, Mark C.; Hardy, Karen; Edwards, Sandie; Adamkiewicz, Thomas; Barkovich, James; Bernaudin, Francoise; Buchanan, George R.; Bunin, Nancy; Dickerhoff, Roswitha; Giller, Roger; Haut, Paul R.; Horan, John; Hsu, Lewis L.; Kamani, Naynesh; Levine, John E.; Margolis, David; Ohene-Frempong, Kwaku; Patience, Melinda; Redding-Lallinger, Rupa; Roberts, Irene A G; Rogers, Zora R.; Sanders, Jean E.; Scott, J. Paul; Sullivan, Keith M.

In: Biology of Blood and Marrow Transplantation, Vol. 16, No. 2, 02.2010, p. 263-272.

Research output: Contribution to journalArticle

Walters, MC, Hardy, K, Edwards, S, Adamkiewicz, T, Barkovich, J, Bernaudin, F, Buchanan, GR, Bunin, N, Dickerhoff, R, Giller, R, Haut, PR, Horan, J, Hsu, LL, Kamani, N, Levine, JE, Margolis, D, Ohene-Frempong, K, Patience, M, Redding-Lallinger, R, Roberts, IAG, Rogers, ZR, Sanders, JE, Scott, JP & Sullivan, KM 2010, 'Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease', Biology of Blood and Marrow Transplantation, vol. 16, no. 2, pp. 263-272. https://doi.org/10.1016/j.bbmt.2009.10.005
Walters, Mark C. ; Hardy, Karen ; Edwards, Sandie ; Adamkiewicz, Thomas ; Barkovich, James ; Bernaudin, Francoise ; Buchanan, George R. ; Bunin, Nancy ; Dickerhoff, Roswitha ; Giller, Roger ; Haut, Paul R. ; Horan, John ; Hsu, Lewis L. ; Kamani, Naynesh ; Levine, John E. ; Margolis, David ; Ohene-Frempong, Kwaku ; Patience, Melinda ; Redding-Lallinger, Rupa ; Roberts, Irene A G ; Rogers, Zora R. ; Sanders, Jean E. ; Scott, J. Paul ; Sullivan, Keith M. / Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease. In: Biology of Blood and Marrow Transplantation. 2010 ; Vol. 16, No. 2. pp. 263-272.
@article{61227a2d748441a0a98f97e17ac44f36,
title = "Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease",
abstract = "We conducted a prospective, multicenter investigation of human-leukocyte antigen (HLA) identical sibling bone marrow transplantation (BMT) in children with severe sickle cell disease (SCD) between 1991 and 2000. To determine if children were protected from complications of SCD after successful BMT, we extended our initial study of BMT for SCD to conduct assessments of the central nervous system (CNS) and of pulmonary function 2 or more years after transplantation. In addition, the impact on gonadal function was studied. After BMT, patients with stroke who had stable engraftment of donor cells experienced no subsequent stroke events after BMT, and brain magnetic resonance imaging (MRI) exams demonstrated stable or improved appearance. However, 2 patients with graft rejection had a second stroke after BMT. After transplantation, most patients also had unchanged or improved pulmonary function. Among the 11 patients who had restrictive lung changes at baseline, 5 were improved and 6 had persistent restrictive disease after BMT. Of the 2 patients who had obstructive changes at baseline, 1 improved and 1 had worsened obstructive disease after BMT. There was, however, significant gonadal toxicity after BMT, particularly among female recipients. In summary, individuals who had stable donor engraftment did not experience sickle-related complications after BMT, and were protected from progressive CNS and pulmonary disease.",
keywords = "Bone marrow transplantation, Long-term follow-up, Sickle cell anemia",
author = "Walters, {Mark C.} and Karen Hardy and Sandie Edwards and Thomas Adamkiewicz and James Barkovich and Francoise Bernaudin and Buchanan, {George R.} and Nancy Bunin and Roswitha Dickerhoff and Roger Giller and Haut, {Paul R.} and John Horan and Hsu, {Lewis L.} and Naynesh Kamani and Levine, {John E.} and David Margolis and Kwaku Ohene-Frempong and Melinda Patience and Rupa Redding-Lallinger and Roberts, {Irene A G} and Rogers, {Zora R.} and Sanders, {Jean E.} and Scott, {J. Paul} and Sullivan, {Keith M.}",
year = "2010",
month = "2",
doi = "10.1016/j.bbmt.2009.10.005",
language = "English (US)",
volume = "16",
pages = "263--272",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease

AU - Walters, Mark C.

AU - Hardy, Karen

AU - Edwards, Sandie

AU - Adamkiewicz, Thomas

AU - Barkovich, James

AU - Bernaudin, Francoise

AU - Buchanan, George R.

AU - Bunin, Nancy

AU - Dickerhoff, Roswitha

AU - Giller, Roger

AU - Haut, Paul R.

AU - Horan, John

AU - Hsu, Lewis L.

AU - Kamani, Naynesh

AU - Levine, John E.

AU - Margolis, David

AU - Ohene-Frempong, Kwaku

AU - Patience, Melinda

AU - Redding-Lallinger, Rupa

AU - Roberts, Irene A G

AU - Rogers, Zora R.

AU - Sanders, Jean E.

AU - Scott, J. Paul

AU - Sullivan, Keith M.

PY - 2010/2

Y1 - 2010/2

N2 - We conducted a prospective, multicenter investigation of human-leukocyte antigen (HLA) identical sibling bone marrow transplantation (BMT) in children with severe sickle cell disease (SCD) between 1991 and 2000. To determine if children were protected from complications of SCD after successful BMT, we extended our initial study of BMT for SCD to conduct assessments of the central nervous system (CNS) and of pulmonary function 2 or more years after transplantation. In addition, the impact on gonadal function was studied. After BMT, patients with stroke who had stable engraftment of donor cells experienced no subsequent stroke events after BMT, and brain magnetic resonance imaging (MRI) exams demonstrated stable or improved appearance. However, 2 patients with graft rejection had a second stroke after BMT. After transplantation, most patients also had unchanged or improved pulmonary function. Among the 11 patients who had restrictive lung changes at baseline, 5 were improved and 6 had persistent restrictive disease after BMT. Of the 2 patients who had obstructive changes at baseline, 1 improved and 1 had worsened obstructive disease after BMT. There was, however, significant gonadal toxicity after BMT, particularly among female recipients. In summary, individuals who had stable donor engraftment did not experience sickle-related complications after BMT, and were protected from progressive CNS and pulmonary disease.

AB - We conducted a prospective, multicenter investigation of human-leukocyte antigen (HLA) identical sibling bone marrow transplantation (BMT) in children with severe sickle cell disease (SCD) between 1991 and 2000. To determine if children were protected from complications of SCD after successful BMT, we extended our initial study of BMT for SCD to conduct assessments of the central nervous system (CNS) and of pulmonary function 2 or more years after transplantation. In addition, the impact on gonadal function was studied. After BMT, patients with stroke who had stable engraftment of donor cells experienced no subsequent stroke events after BMT, and brain magnetic resonance imaging (MRI) exams demonstrated stable or improved appearance. However, 2 patients with graft rejection had a second stroke after BMT. After transplantation, most patients also had unchanged or improved pulmonary function. Among the 11 patients who had restrictive lung changes at baseline, 5 were improved and 6 had persistent restrictive disease after BMT. Of the 2 patients who had obstructive changes at baseline, 1 improved and 1 had worsened obstructive disease after BMT. There was, however, significant gonadal toxicity after BMT, particularly among female recipients. In summary, individuals who had stable donor engraftment did not experience sickle-related complications after BMT, and were protected from progressive CNS and pulmonary disease.

KW - Bone marrow transplantation

KW - Long-term follow-up

KW - Sickle cell anemia

UR - http://www.scopus.com/inward/record.url?scp=75149170038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149170038&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2009.10.005

DO - 10.1016/j.bbmt.2009.10.005

M3 - Article

VL - 16

SP - 263

EP - 272

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 2

ER -